Galen Growth Asia: European Expansion Plans Revealed
As Vas Narasimhan, Novartis’ global CEO, put so succinctly at the World Economic Forum, “going big on data and digital will be one of the keys to Novartis’ future” and that of healthcare.
Galen Growth Asia (GGA) is the leading, exclusively HealthTech, research, analytics and advisory firm in Asia Pac serving Fortune 500 companies and global investors. With our commitment to accelerating the timeline to ROI of a digital strategy, we have built a unique analytics platform which assesses and evaluates the maturity of the majority of the 4000+ HealthTech ventures in Asia Pac.
To respond to the growing demand and needs of its continuously expanding client base of healthcare incumbents, new entrants and investors, GGA is excited to announce it is expanding its footprint to include Europe.
The synergy between the two continents has never been stronger and the creation of a larger ecosystem will offer all stakeholders greater depth and access through our solutions.
Making Europe’s HealthTech ecosystem part of the larger Asia Pac community which GGA has built since its inception will enable companies, startups, investors, clinicians, scientists, patients and suppliers to scale to the next level of healthcare innovation transformation.
Similarly to Asia Pac, GGA will position itself at the epicentre of HealthTech innovation across Europe to be the go-to-reference for digital health across the region for enterprise, investors and startups to better address their needs through the bridging these two vibrant ecosystems.
“We strongly believe that extending our value proposition and reach, will create unique and valuable opportunities for both our existing and prospective clients, reflecting their quest to enable the future of healthcare, by broadening perspectives through the identification of new trends and the creation of potential deals and partnerships”
– Julien de Salaberry, CEO & co-founder, Galen Growth Asia
GGA will be establishing its European headquarters in Basel (Switzerland), the home of healthcare leaders such as Roche, Novartis, Bayer, amongst many others, during the course of Q2 2019.
Notwithstanding our imminent geographic expansion, Asia Pac’s extremely promising HealthTech ecosystem will remain at the core of GGA’s focus and activities with the team growing to better serve all our stakeholders with ongoing discussion with strategic investors.
GGA will continue to deliver its HealthTech strategy acceleration services and will be launching the next generation of its HealthTech Alpha platform in April 2019. You can also look forward to the next edition of our much sought-after annual HealthTech Summit on November 14-15, 2019 in Singapore with innovation labs dedicated to fostering collaboration between the 50 most promising HealthTech CEOs in Asia and leading corporates and investors.
For all enquiries, please contact us at: email@example.com
All around the world, HealthTech is creating profound transformations impacting millions of lives every day. This is why, the team at GGA thrives in building an ecosystem that has true social impact in the communities we serve in Asia and will continue to do so today and into the future. Our unique analytics platform which assesses and evaluates the maturity and value proposition of the majority of the 4000+ HealthTech ventures in Asia Pac, will be integrating European startups as part of this expansion, reflecting our ambitions of having stronger collaboration between both continents.
After 3 years of working relentlessly in building the HealthTech ecosystem in Asia and seeing startups scaling together with a record-breaking funding year, GGA’s mission has never been stronger and more relevant. The pool of innovation has never been more robust. And our commitment to accelerating our clients’ innovation journey is unshaken. We strongly believe that extending our value proposition and reach will create unique opportunities for both ecosystems, enabling the future of healthcare, by creating potential deals and partnerships. In times of great market uncertainty and geopolitical instability, we believe there has never been a better moment to seize the opportunity to be stronger together.
What does that mean for the GGA team?
December 15th, 2015 marked GGA’s first day, where a group of HealthTech innovators decided to take a leap of faith in building an ecosystem still nascent but promising. The ambition was to bring the next generation of HealthTech innovators visible to all by bringing them at the centre stage of the ecosystem and thereby connecting all stakeholders to help accelerate innovation. A few months later, a founding team was hired with a common passion for digital health and its impact of the lives of billions of people. Stronger than ever and excited about the expansion of our mission, the Asia Pac team will continue to serve the growing community of HealthTech innovators, support the expansion into Europe and build the team with our shared value.
What does it mean for our clients?
Notwithstanding our imminent geographic expansion, Asia Pac’s extremely promising HealthTech ecosystem will remain at the core of GGA’s focus and activities, with the team growing to better serve all our stakeholders with ongoing discussion with strategic investors. GGA will continue to deliver its HealthTech strategy acceleration services and will be launching the next generation of its HealthTech Alpha platform in April 2019. Having both the European and Asian HealthTech innovators connected with help fostering better collaboration between corporates and startups by creating new sources of innovation to fuel the transformation of healthcare.
Will there be a HealthTech Summit in 2019?
You can look forward to the next edition of our much sought-after annual HealthTech Summit on November 14-15, 2019 in Singapore with innovation labs dedicated to fostering collaboration between the 50 most promising HealthTech startups CEOs in Asia along with leading corporates and investors. This year HealthTech Summit will also be part of the innovation lab crawl of the FinTech Festival and will have sessions open to the public with the mission of bringing more awareness to the space.
Basel is nestled right at the border of France and Germany and is a major economic hub of the region. It is a major centre for science and research with pharmaceutical products exports accounting for more than US$52B.
It is home to major multinational corporations like Roche, Novartis, Actelion, Abbott, Lonza and more than 700 other life sciences companies. Basel boasts of a huge life sciences workforce with top global talent across the value chain – from basic research to commercialisation, easy access and flight connections throughout Europe, one of the most liberal labour laws in Europe and a very competitive corporate tax model.
© Galen Growth Asia